- Xiao Xu, Jun Chen, Qiang Wei, Zhi-Kun Liu, Zhe Yang, Ming Zhang, Guo-Ying Wang, Jie Gao, Zhao-Xu Yang, Wen-Yuan Guo, Tong-Hai Xing, Zhou Shao, Qin-Fen Xie, Shu-Sen Zheng. Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition). Hepatobiliary & Pancreatic Diseases International 2019;18:307

- Xue-Qin Meng, Xin-Hua Chen, Zayd Sahebally, Yu-Ning Xu, Sheng-Yong Yin, Li-Ming Wu, Shu-Sen Zheng. Cytokines are early diagnostic biomarkers of graft-versus-host disease in liver recipients. Hepatobiliary & Pancreatic Diseases International 2017;16:45

- Khurram Bari, Shimul A. Shah, Tiffany E. Kaiser, Robert M. Cohen, Nadeem Anwar, David Kleesattel, Kenneth E. Sherman. Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial. Liver Transpl. 2020;26:1430

- Eva Maria Teegen, Max Magnus Maurer, Brigitta Globke, Johann Pratschke, Dennis Eurich. Liver transplantation for Hepatitis‐B‐associated liver disease ‐ Three decades of experience. Transplant Infectious Dis 2019;21

- Xueqin Meng, Xinhua Chen, Liming Wu, Shusen Zheng. The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy. Journal of Immunology Research 2017;2017:1

- Qiang Wei, Kun Wang, Modan Yang, Junli Chen, Tian Shen, Penghong Song, Haiyang Xie, Lin Zhou, Shusen Zheng, Xiao Xu. Recipient gender and body mass index are associated with early acute rejection in donation after cardiac death liver transplantation. Clinics and Research in Hepatology and Gastroenterology 2020;44:100004

- Victor M. Zaydfudim, Shawn J. Pelletier. Towards Steroid-Free Immunosuppression after Liver Transplantation. Gut and Liver 2016;10:495

- Umberto Cillo, Wolf O. Bechstein, Gabriela Berlakovich, Philipp Dutkowski, Frank Lehner, Silvio Nadalin, Faouzi Saliba, Hans J. Schlitt, Johann Pratschke. Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression. Transplantation Reviews 2018;32:142

- Daniel Hoffman, Neil Mehta. Recurrence of hepatocellular carcinoma following liver transplantation. Expert Review of Gastroenterology & Hepatology 2021;15:91

- Tommaso Maria Manzia, Barbara Antonelli, Amedeo Carraro, Grazia Conte, Nicola Guglielmo, Andrea Lauterio, Laura Mameli, Umberto Cillo, Luciano De Carlis, Massimo Del Gaudio, Paolo De Simone, Stefano Fagiuoli, Francesco Lupo, Giuseppe Tisone, Riccardo Volpes. Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group. Hepatol Int 2024;18:1416

- Yasuhiko Sugawara, Taizo Hibi. Liver transplantation for patients with hepatocellular carcinoma: Its current status and advances. BST 2022;16:207

- Umberto Cillo, Amedeo Carraro, Alfonso W. Avolio, Matteo Cescon, Fabrizio Di Benedetto, Valerio Giannelli, Paolo Magistri, Daniele Nicolini, Marco Vivarelli, Jacopo Lanari, Salvatore Agnes, Enzo Andorno, Umberto Baccarani, Lucio Caccamo, Michele Colledan, Luciano De Carlis, Paolo De Simone, Giuseppe Maria Ettorre, Salvatore Gruttadauria, Vincenzo Mazzaferro, Renato Romagnoli, Massimo Rossi, Francesco Tandoi, Giuseppe Tisone, Giovanni Vennarecci, Fausto Zamboni. Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT). Updates Surg 2024;76:725

- Tingxiao Zhao, Zhe Yang, Jiong Yu, Juan Lu, Lanjuan Li, Xiao Xu, Hongcui Cao, Shusen Zheng, Hang Xiao. Comparing Long-Term Outcomes of Entecavir and Tenofovir Disoproxil Fumarate in Liver Transplant Patients. Advanced Gut & Microbiome Research 2022;2022:1
